AT IMPF
AT IMPF
Founded:
2010-01-01
Status:
Active
Similar Organizations
Edbru AG
Edbru AG was added in 2014.
Gemeente Delft
Gemeente Delft is over 750 years old, the city owes its name to the 'digging' of the oldest canal, the Oude Delft.
Growth Tech Ventures, Inc
Growth Tech Ventures, Inc was added in 2013.
SS Capital
SS Capital was added in 2010.
VIR
VIR was added in 2013.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-03-17 | immatics biotechnologies | AT Impf investment in Post-IPO Equity - immatics biotechnologies | 104 M USD |
| 2017-10-04 | immatics biotechnologies | AT Impf investment in Series E - immatics biotechnologies | 58 M USD |
| 2014-07-16 | immatics biotechnologies | AT Impf investment in Series D - immatics biotechnologies | 22 M EUR |
| 2014-01-07 | Isarna Therapeutics | AT Impf investment in Venture Round - Isarna Therapeutics | 17.8 M USD |
| 2013-10-15 | immatics biotechnologies | AT Impf investment in Series D - immatics biotechnologies | 12 M EUR |
| 2010-09-21 | immatics biotechnologies | AT Impf investment in Series C - immatics biotechnologies | 54 M EUR |
More informations about "AT Impf"
Backgrounder: Government of Canada announces additional …
Oct 12, 2022 Lead organization: Digital Public Square. Project Name: Leveraging Digital Tools to Increase COVID-19 Vaccine Adoption. Description: This project is working to reduce the spread of vaccine misinformation with a "gamified" platform built to help users explore the latest …See details»
Immunization Partnership Fund - Canada.ca
The project aims to leverage the organization's leadership and expertise of its 100+ Community Health Centres members to enhance vaccine uptake among equity-deserving populations …See details»
Gavi, the Vaccine Alliance
Back to Gavi's 2023 progress report Leaving no one behind with immunisation. Since Gavi was established in 2000 with a mission to save lives, reduce poverty and protect the world against …See details»
Call for applications to the Immunization Partnership Fund: …
‘Biotech is the ultimate impact investment’ — family offices can’t …
May 15, 2023 They own 43.5 per cent of BioNTech through an investment vehicle called AT Impf, according to a recent SEC filing, making their stake worth around $14bn. “It’s a great …See details»
About our Alliance - GAVI
Oct 11, 2024 Gavi’s impact draws on the strengths of its core partners, the World Health Organization, UNICEF, the World Bank and the Bill & Melinda Gates Foundation, and plays a …See details»
BioNTech - Wikipedia
BioNTech was founded in 2008 based on research by Uğur Şahin, Özlem Türeci, [13] and Christoph Huber, [14] with a seed investment of €150 million from MIG Capital, a Munich …See details»
immatics Raises EUR54 Million to Advance its Late Stage Clinical ...
Sep 21, 2010 AT Impf GmbH is a wholly owned company of Dr. Andreas and Dr. Thomas Strungmann. The company holds several Biotech-Investments and is managed by the Family …See details»
AT Impf GmbH
Find company research, competitor information, contact details & financial data for AT Impf GmbH of München, Bayern. Get the latest business insights from Dun & Bradstreet.See details»
Backgrounder: New Projects Funded Under the Immunization …
Jul 12, 2021 Lead organization: Regina Treaty / Status Indian Services Inc. Project Name: Regina Urban Indigenous COVID-19 Vaccination Strategy Description: This project will …See details»
SC 13G - SEC.gov
This Schedule 13G is being jointly filed by ATHOS KG, AT Impf GmbH, Helmut Jeggle and Thomas Maier, each of the foregoing, a “Reporting Person,” and collectively, the “Reporting …See details»
SEC.gov | HOME
ATHOS KG, Holzkirchen, Germany is the sole shareholder of AT Impf GmbH, Munich, Germany and beneficial owner of our ordinary shares. Entities controlled by ATHOS KG mainly provide …See details»
AT Impf Investor Profile: Portfolio & Exits - PitchBook
AT Impf's latest investment was on 04-Oct-2017 in Immatics, a company within the Biotechnology industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure …See details»
What Kind Of Shareholders Hold The Majority In BioNTech SE's
Nov 9, 2021 AT Impf GmbH is currently the company's largest shareholder with 47% of shares outstanding. For context, the second largest shareholder holds about 17% of the shares …See details»
SC 13G/A - SEC.gov
This Amendment No. 1 to Schedule 13G is being jointly filed by ATHOS KG, AT Impf GmbH, Helmut Jeggle and Thomas Maier, each of the foregoing, a “Reporting Person,” and …See details»
Backgrounder: Two New Projects Funded Under the Immunization ...
Jul 27, 2021 Lead organization: Canada Safety Council. Project Name: Elmer Vaccine Education and Awareness Program. Description: Through this project, the Canada Safety …See details»
Three Immunization Leaders Tell Us Why Gavi Matters | Bill
Jun 20, 2024 When families aren’t losing their children to disease, communities and economies blossom. That’s why I launched AFRIVAC, a nongovernmental organization that involves the …See details»
I.M.F. Board Backs $650 Billion Aid Plan to Help Poor Countries
Jul 9, 2021 The I.M.F., the World Bank, the World Health Organization and the World Trade Organization have created a new vaccine task force and called for an additional $50 billion …See details»
Government of Canada announces additional funding for nine …
Oct 12, 2022 Launched in 2016, the Immunization Partnership Fund (IPF) is a key element of the Public Health Agency of Canada’s vaccination initiatives. The IPF is an important lever to …See details»
Meet Twin Brother Billionaires Behind BioNTech’s Success
Feb 8, 2022 These investments lead to AT Impf being the controlling shareholder at the time of the IPO at Nasdaq on October 10th, 2019, owning 50,2% of the company. The MIG Fonds …See details»